Industries
Cosmetics
Modernized cosmetics requirements introduced registration, listing, adverse event reporting and safety substantiation obligations for organizations that previously had few formal FDA interactions.
xFDA supports cosmetic manufacturers and brand owners with manufacturing quality systems, MoCRA-related facility registration and product listing obligations, safety substantiation records, adverse event recordkeeping, contract manufacturer oversight and audits.
How we support this sector
Where engagements typically focus
- Facility registration and product listing obligations
- Manufacturing quality systems and good manufacturing practice alignment
- Safety substantiation records and documentation
- Adverse event recordkeeping and reporting processes
- Contract manufacturer oversight and quality agreements
- Labeling review and recordkeeping practices
We help cosmetics organizations put proportionate systems in place without adopting pharmaceutical-scale bureaucracy.
When companies call us
Situations we are asked into
- A brand has registration and listing obligations for the first time.
- Safety substantiation exists as marketing material rather than as records.
- Adverse event reports arrive through customer service with no defined process.
- A contract manufacturer's practices have never been audited.
- Batch documentation cannot demonstrate what went into a specific lot.
Questions we are asked
Cosmetics: common questions
Direct answers from the consultants who do this work.
- What did MoCRA change for cosmetics companies?
- It introduced facility registration, product listing, adverse event recordkeeping and reporting, and safety substantiation obligations, and gave FDA additional authorities. Companies that previously had almost no formal FDA interaction now need records that can be produced on request.
- What counts as adequate safety substantiation?
- Tests, studies, research, analyses or other evidence that a qualified expert would consider sufficient to support that the product is safe under labeled or customary conditions of use — held as records, not as a supplier assurance email.
- Do cosmetics manufacturers need GMP?
- Cosmetic good manufacturing practice expectations are developing under MoCRA. Practically, manufacturers should already control sanitation, water quality, preservative efficacy, batch records, component specifications and cleaning between products.
- Who is responsible when a contract manufacturer produces the product?
- The responsible person for the product carries the obligations. That requires documented manufacturer qualification, agreed specifications, batch record access and a defined complaint and adverse event flow back from the manufacturer.
- How should adverse events be handled?
- With a written procedure defining intake from every channel, medical assessment criteria, recordkeeping content and retention, escalation for serious events, and periodic trending — so reportability decisions are consistent and evidenced.
Newsletter
Insights from Former FDA & Industry Experts
Practical perspectives on GMP, quality systems, validation, manufacturing and development — written by the consultants doing the work. No newsletter-only sales pitches.
Start a project
Tell us what you're working on.
Describe the product, the process or the problem. We will tell you honestly whether we are the right people to help, and who should be on the team if we are.